Founded in 1983, Gen-Probe is a San Diego, California-based company which employs approximately 1,300 people (as of January 2011). The company specializes in molecular diagnostics and was the recipient of the 2004 National Medal of Technology. Gen-Probe makes testing materials for a variety of conditions in a number of medical fields.
Gen-Probe's key product and service areas include women's heath, prostate oncology, transplant diagnostics and blood screening. They also have tests for infectious and molecular diseases.
In 2010, Gen-Probe unveiled a urine test to screen for prostate cancer. The PCA3 test, presented at the American Urological Association in San Francisco, California in June 2010 is reported to have a lower false positive rate than much more intrusive biopsies.
In addition to testing, Gen-Probe developed instrumentation platforms including hardware and software platforms specially designed for health care and biotech labs. The company also provides DNA extraction and purification kits for laboratory environments.
Justin Beach has been writing for more than a decade, contributing to a variety of online publications. He has a Bachelor of Science in computer information systems and additional education in business, economics, political science, media and the arts.